A Multicenter, Open-label Study to Evaluate Ovarian Follicular Activity and Hormone Levels With the Oral Contraceptive Regimen DR-102 Compared to Two 28-day Oral Contraceptive Regimens Containing Different Synthetic Progestins.

Trial Profile

A Multicenter, Open-label Study to Evaluate Ovarian Follicular Activity and Hormone Levels With the Oral Contraceptive Regimen DR-102 Compared to Two 28-day Oral Contraceptive Regimens Containing Different Synthetic Progestins.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Aug 2013

At a glance

  • Drugs Ethinylestradiol/desogestrel (Primary) ; Drospirenone/ethinylestradiol; Ethinylestradiol; Ethinylestradiol/levonorgestrel
  • Indications Pregnancy
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 May 2013 Status changed from active, no longer recruiting to completed, based on 61st ACOG abstract.
    • 08 May 2013 Results presented at the 61st Annual Clinical Meeting of the American College of Obstetricians and Gynecologists.
    • 08 May 2013 Results were presented at the 61st Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists (ACOG), according to a Teva Women's Health media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top